Free Cooler. Join for Life.

Racial and Ethnic Disparities Exist in Prescribing Rifaximin for Patients with Hepatic Encephalopathy

April 1, 2022

 • 

Read time:

<5 mins
Share on facebook
Share on twitter
Share on reddit
Share on email
Share on print
Pills Medicine Liver Organ Teal 0
Share on facebook
Share on twitter
Share on reddit
Share on email
Share on print
Presented by Health Lab

A new study from Michigan Medicine found that Black Americans experience significant health inequities when receiving treatment for hepatic encephalopathy, a cirrhosis-related disorder. Elliot Tapper, M.D, a hepatologist and associate professor of internal medicine, discusses the inspiration for the study and highlights key findings. The goal of the research was not only to improve care for patients with chronic liver disease but also to help provide more equitable access to life-saving therapies for all, regardless of the condition.

More from the Alumni Education Gateway
Join the Alumni Education Gateway Email List​
We use cookies to ensure you get the best experience on our website. By using this site, you accept our use of cookies.